Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer

被引：7
|
作者：
Al-Obeidi, Ebaa [1 ]
Riess, Jonathan W. [1 ]
Malapelle, Umberto [2 ]
Rolfo, Christian [3 ]
Gandara, David R. [1 ]
机构：
[1] Univ Calif Davis, Div Hematol Oncol, 4501 10 St,Suite 3016, Sacramento, CA 95817 USA
[2] Univ Naples Federico II, Dept Publ Hlth, Via Sergio Pansini 5, I-80131 Naples, Italy
[3] Icahn Sch Med Mt Sinai, Ctr Thorac Oncol, Tisch Canc Inst, One Gustave Levy Pl,Box 1079, New York, NY 10029 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 03期
关键词：
Liquid biopsy; Circulating tumor DNA (ctDNA); Next-generation sequencing (NGS); Minimal residual disease (MRD); Tumor mutational burden (TMB); Non-small cell lung cancer (NSCLC); CIRCULATING TUMOR DNA; RESIDUAL DISEASE; CLINICAL UTILITY; RESISTANCE; LANDSCAPE; BLOCKADE;
D O I：
10.1016/j.hoc.2023.02.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：475 / 487
页数：13
相关论文
共 50 条
  • [1] Liquid Biopsy Promotes Non-Small Cell Lung Cancer Precision Therapy
    Lu, Jun
    Han, Baohui
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2018, 17 : 1 - 7
  • [2] Liquid Biopsy in Non-Small Cell Lung Cancer
    Molina-Vila, Miguel A.
    Mayo-de-las-Casas, Clara
    Gimenez-Capitan, Ana
    Jordana-Ariza, Nuria
    Garzon, Monica
    Balada, Ariadna
    Villatoro, Sergi
    Teixido, Cristina
    Garcia-Pelaez, Beatriz
    Aguado, Cristina
    Jose Catalan, Maria
    Campos, Raquel
    Perez-Rosado, Ana
    Bertran-Alamillo, Jordi
    Martinez-Bueno, Alejandro
    Gil, Maria-de-los-Lianos
    Gonzalez-Cao, Maria
    Gonzalez, Xavier
    Morales-Espinosa, Daniela
    Viteri, Santiago
    Karachaliou, Niki
    Rosell, Rafael
    FRONTIERS IN MEDICINE, 2016, 3
  • [3] Metabolic reprogramming in non-small cell lung cancer: a precision oncology approach
    Tavassoly, Iman
    Iyengar, Ravi
    CANCER RESEARCH, 2017, 77
  • [4] Liquid biopsy in non-small cell lung cancer: come of age
    Ahn, Myung-Ju
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S629 - S631
  • [5] Liquid Biopsy Mutation Profiling in Non-Small Cell Lung Cancer
    Gedvilaite, V.
    Sestokaite, A.
    Sabaliauskaite, R.
    Jarmalaite, S.
    Cicenas, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S256 - S257
  • [6] Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges
    Rijavec, Erika
    Coco, Simona
    Genova, Carlo
    Rossi, Giovanni
    Longo, Luca
    Grossi, Francesco
    CANCERS, 2020, 12 (01)
  • [7] Atezolizumab in non-small cell lung cancer: the era of precision immuno-oncology
    Chow, James Chung Hang
    Cheung, Ka Man
    Cho, William Chi Shing
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (12)
  • [8] Overview of the Role of Liquid Biopsy in Non-small Cell Lung Cancer (NSCLC)
    Ospina, A. V.
    CLINICAL ONCOLOGY, 2024, 36 (10) : e371 - e380
  • [9] Use of Liquid Biopsy in the Care of Patients with Non-Small Cell Lung Cancer
    Romero, Atocha
    Serna-Blasco, Roberto
    Calvo, Virginia
    Provencio, Mariano
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (10)
  • [10] Update on liquid biopsy in clinical management of non-small cell lung cancer
    Wu, Zhen
    Yang, Zhen
    Dai, Yu
    Zhu, Qiang
    Chen, Liang-An
    ONCOTARGETS AND THERAPY, 2019, 12 : 5097 - 5109
12345